ARL3 and hepatocellular carcinoma: Rao et al. reported that YTHDC1 could bound to the m6A-modified circ-ARL3 to promote its back splicing and biogenesis and circ-ARL3 facilitated the Hepatitis B virus-associated hepatocellular carcinoma progression via sponging miR-1305 [32].